How one of the nation’s largest orthopedic MSOs plans to grow in 2023

U.S. Orthopaedic Partners, one of the largest orthopedic management services organizations in the U.S., made major strides in 2022. 

Advertisement

The MSO, founded in 2020, began 2022 with six affiliate practices, but acquired its ninth in 2022. U.S. Orthopaedic now supports 170 providers across 39 locations in Alabama and Mississippi. 

U.S. Orthopaedic Partners’ CEO, Glen Silverman, has outlined the key ways that the MSO plans to grow in 2023. 

Question: How does your organization plan to grow in 2023? 

Glen Silverman: U.S. Orthopaedic Partners was founded in late 2020 on the thesis that creating a high functioning MSO would help create value for the physician owners of USOP.  For the MSO to function at an optimum level we focus on the following value guiding principles: 

  1. Acquire high quality groups with strong reputations and strong growth trajectories. 
  2. Actively engage with those practices, adding additional expertise around practice growth opportunities, adding and expanding services lines, expense management and supply synergy opportunities.
  3. Integration, management and support of the redundant business functions; accounting, payroll, compliance marketing etc.      

In 2023, the MSO, through its management team, will stay laser focused on these guiding principles and will continue to add value to the groups and physician owners we serve. Regarding growth, we plan to stay focused on the Southeastern United States and engage with orthopedic practices offering the opportunity for growth and support through our guiding principles. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.